Mark M. Gitau

Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study

Steven Powell, Kathryn A. Gold, Mark M. Gitau et al. · Journal of Clinical Oncology · 2020 · 119 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Safety of pembrolizumab with chemoradiation (CRT) in locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN).

Steven Powell, Mark M. Gitau, Christopher Sumey et al. · Journal of Clinical Oncology · 2017 · 59 citations

Medicine, Oncology, Pharmacology +17

Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial

Douglas R. Adkins, Jessica Ley, Omar Atiq et al. · Oral Oncology · 2021 · 29 citations · Full text

Medicine, Oncology, Pharmacology +16

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Sonja Althammer, Keith E. Steele, Marlon C. Rebelatto et al. · Journal for ImmunoTherapy of Cancer · 2016 · 17 citations · Full text

Medicine, Immunology, Oncology +17

nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trial

Peter Oppelt, Jessica Ley, Mackenzie Daly et al. · Medical Oncology · 2021 · 16 citations

Medicine, Oncology, Radiation Oncology +14